Alternative TFAP2A isoforms have distinct activities in breast cancer

Breast Cancer Research

Volumn 13, Issue 2, 2011, Pages

  Berlato, Chiara ^a   Chan, KaYi V ^a   Price, Anna M ^a   Canosa, Monica ^a   Scibetta, Angelo G ^a   Hurst, Helen C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYCLIN D3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOPROTEIN; PROTEIN P300; TAMOXIFEN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSCRIPTION FACTOR AP 2ALPHA 1B; TRANSCRIPTION FACTOR AP 2ALPHA 1C; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; MESSENGER RNA; MONOCLONAL ANTIBODY; SUMO PROTEIN; TFAP2A PROTEIN, HUMAN; XENOPUS PROTEIN; ZEBRAFISH PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROMOTER REGION; PROTEIN MOTIF; TRANSACTIVATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; TRANSCRIPTION INITIATION; TUMOR CELL LINE; XENOPUS; ZEBRA FISH;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN D3; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RECEPTOR, ERBB-2; RNA, MESSENGER; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TAMOXIFEN; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; XENOPUS; XENOPUS PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84860402089     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2838     Document Type: Article

References (30)

1. Eckert D, Buhl S, Weber S, Jäger R, Schorle H. The AP-2 family of transcription factors. Genome Biol 2005, 6:246. 10.1186/gb-2005-6-13-246, 1414101, 16420676.
2. Friedrichs N, Jäger R, Paggen E, Rudlowski C, Merkelbach-Bruse S, Schorle H, Buettner R. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 2005, 18:431-438. 10.1038/modpathol.3800292, 15467710.
3. Friedrichs N, Steiner S, Buettner R, Knoepfle G. Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 2007, 51:814-823. 10.1111/j.1365-2559.2007.02887.x, 18042070.
4. Gee JM, Robertson JF, Ellis IO, Nicholson RI, Hurst HC. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol 1999, 189:514-520. 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9, 10629551.
5. Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma VM. Expression of HER2 and its association with AP-2 in breast cancer. Eur J Cancer 2004, 40:1485-1495. 10.1016/j.ejca.2004.02.020, 15196531.
6. Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 1995, 92:744-747. 10.1073/pnas.92.3.744, 42696, 7846046.
7. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 1998, 58:5466-5472.
8. Pellikainen JM, Kosma VM. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. Int J Cancer 2007, 120:2061-2067. 10.1002/ijc.22648, 17330235.
9. Bragança J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, Bhattacharya S. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 2003, 278:16021-16029.
10. Bragança J, Swingler T, Marques FIR, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S. Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 2002, 277:8559-8565.
11. Bamforth SD, Braganca J, Eloranta JJ, Murdoch JN, Marques FI, Kranc KR, Farza H, Henderson DJ, Hurst HC, Bhattacharya S. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 2001, 29:469-474. 10.1038/ng768, 11694877.
12. Jiang MS, Tang QQ, McLenithan J, Geiman D, Shillinglaw W, Henzel WJ, Lane MD. Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor. Proc Natl Acad Sci USA 1998, 95:3467-3471. 10.1073/pnas.95.7.3467, 19859, 9520389.
13. Wajapeyee N, Britto R, Ravishankar HM, Somasundaram K. Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2. J Biol Chem 2006, 281:16207-16219. 10.1074/jbc.M600539200, 16533807.
14. Wang X. AP-2: a regulator of EGF receptor signaling and proliferation in skin epidermis. J Cell Biol 2006, 172:409-421. 10.1083/jcb.200510002, 2063650, 16449191.
15. Eloranta JJ, Hurst HC. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem 2002, 277:30798-30804. 10.1074/jbc.M202780200, 12072434.
16. Meier P, Koedood M, Philipp J, Fontana A, Mitchell PJ. Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis. Dev Biol 1995, 169:1-14. 10.1006/dbio.1995.1121, 7750631.
17. Limesand SW, Anthony RV. Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene. Eur J Biochem 2001, 268:2390-2401. 10.1046/j.1432-1327.2001.02124.x, 11298758.
18. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH. The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 2008, 24:167-177. 10.1016/j.tig.2008.01.008, 18329129.
19. Williams T, Admon A, Lüscher B, Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 1988, 2:1557-1569. 10.1101/gad.2.12a.1557, 3063603.
20. Boyes J, Byfield P, Nakatani Y, Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 1998, 396:594-598. 10.1038/25166, 9859997.
21. Soutoglou E, Katrakili N, Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 2000, 5:745-751. 10.1016/S1097-2765(00)80253-1, 10882110.
22. Hollywood DP, Hurst HC. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J 1993, 12:2369-2375. 413467, 8099545.
23. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
24. ImageJ. , http://rsb.info.nih.gov/ij/
25. Iacono M, Mignone F, Pesole G. uAUG and uORFs in human and rodent 5'untranslated mRNAs. Gene 2005, 349:97-105. 10.1016/j.gene.2004.11.041, 15777708.
26. Gong L, Kamitani T, Fujise K, Caskey LS, Yeh ET. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem 1997, 272:28198-28201. 10.1074/jbc.272.45.28198, 9353268.
27. Vernimmen D, Begon D, Salvador C, Gofflot S, Grooteclaes M, Winkler R. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem J 2003, 370:323-329. 10.1042/BJ20021238, 1223148, 12418962.
28. Arpino G, Wiechmann L, Osborne CK, Schiff R. Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev 2008, 29:217-233. 10.1210/er.2006-0045, 2528847, 18216219.
29. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007, 8:947-956. 10.1038/nrm2293, 18000527.
30. Ramos YF, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, van Galen M, van Dam H, van Ommen GJ, den Dunnen JT, Zantema A, 't Hoen PA. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res 38:5396-5408. 10.1093/nar/gkq184, 2938195, 20435671.